📣 VC round data is live. Check it out!
- Public Comps
- Kusuri No Aoki
Kusuri No Aoki Valuation Multiples
Discover revenue and EBITDA valuation multiples for Kusuri No Aoki and similar public comparables like Omnicell, Ebos Group, Dis-Chem Pharmacies, Fragua and more.
Kusuri No Aoki Overview
About Kusuri No Aoki
Kusuri No Aoki Holdings is a pharmaceutical retail chain that sells health, beauty, and cleaning supplies. The company operates stores that focus primarily on residential areas in Japan. Kusuri's business includes pharmaceutical drugs, and the company also operates a bone-marrow bank. The company breaks out its sales into four different product lines, including health, beauty, life, and dispensing. The vast majority of the company's revenue is derived from its life product category, followed by beauty products. Most of Kusuri's revenue is derived from the Hokuriku region.
Founded
1999
HQ

Employees
8.0K
Website
Sectors
Financials (LTM)
EV
$3B
Valuation Multiples
Start free trialKusuri No Aoki Financials
Kusuri No Aoki reported last 12-month revenue of $4B and EBITDA of $260M.
In the same LTM period, Kusuri No Aoki generated $260M in EBITDA and $117M in net income.
Revenue (LTM)
Kusuri No Aoki P&L
In the most recent fiscal year, Kusuri No Aoki reported revenue of $3B and EBITDA of $270M.
Kusuri No Aoki is profitable as of last fiscal year, with gross margin of 24%, EBITDA margin of 8%, and net margin of 4%.
Financial data powered by Morningstar, Inc.
Kusuri No Aoki Stock Performance
Kusuri No Aoki has current market cap of $2B, and enterprise value of $3B.
Market Cap Evolution
Kusuri No Aoki's stock price is $23.78.
Kusuri No Aoki share price increased by 1.4% in the last 30 days, and by 6.7% in the last year.
Kusuri No Aoki has an EPS (earnings per share) of $1.30.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $3B | $2B | 0.0% | 1.4% | -7.1% | 6.7% | $1.30 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialKusuri No Aoki Valuation Multiples
Kusuri No Aoki trades at 0.8x EV/Revenue multiple, and 10.9x EV/EBITDA.
EV / Revenue (LTM)
Kusuri No Aoki Financial Valuation Multiples
As of May 4, 2026, Kusuri No Aoki has market cap of $2B and EV of $3B.
Kusuri No Aoki has a P/E ratio of 19.3x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Kusuri No Aoki Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Kusuri No Aoki Margins & Growth Rates
Kusuri No Aoki grew revenue by 4% but EBITDA decreased by 4% in the last fiscal year.
In the most recent fiscal year, Kusuri No Aoki reported gross margin of 24%, EBITDA margin of 8%, and net margin of 4%.
Kusuri No Aoki Margins
Kusuri No Aoki Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Kusuri No Aoki Operational KPIs
Kusuri No Aoki's revenue per employee in the last FY averaged $0.4M, while opex per employee averaged $0.1M for the same period.
Kusuri No Aoki's Rule of 40 is 20% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Kusuri No Aoki's Rule of X is 39% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
Kusuri No Aoki Competitors
Kusuri No Aoki competitors include Omnicell, Ebos Group, Dis-Chem Pharmacies, Fragua, Sundrug, LBX Pharmacy, Selçuk Ecza, COSMOS Pharmaceutical, DaShenLin Pharmaceutical and Create SD Holdings.
Most Kusuri No Aoki public comparables operate across Pharmacies.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 1.6x | 1.6x | 13.6x | 12.9x | |||
| 0.5x | 0.4x | 10.7x | 8.4x | |||
| 0.9x | 0.8x | 11.0x | 10.3x | |||
| 0.4x | 0.3x | 7.0x | 4.4x | |||
| 0.5x | 0.5x | 6.3x | 6.3x | |||
| 0.6x | 0.5x | 5.3x | 5.6x | |||
| 0.3x | 0.3x | 10.3x | 8.1x | |||
| 0.5x | 0.5x | 7.7x | 7.7x | |||
This data is available for Pro users. Sign up to see all Kusuri No Aoki competitors and their valuation data. Start Free Trial | ||||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Kusuri No Aoki
| When was Kusuri No Aoki founded? | Kusuri No Aoki was founded in 1999. |
| Where is Kusuri No Aoki headquartered? | Kusuri No Aoki is headquartered in Japan. |
| How many employees does Kusuri No Aoki have? | As of today, Kusuri No Aoki has over 8K employees. |
| Is Kusuri No Aoki publicly listed? | Yes, Kusuri No Aoki is a public company listed on Tokyo Stock Exchange. |
| What is the stock symbol of Kusuri No Aoki? | Kusuri No Aoki trades under 3549 ticker. |
| When did Kusuri No Aoki go public? | Kusuri No Aoki went public in 2006. |
| Who are competitors of Kusuri No Aoki? | Kusuri No Aoki main competitors include Omnicell, Ebos Group, Dis-Chem Pharmacies, Fragua, Sundrug, LBX Pharmacy, Selçuk Ecza, COSMOS Pharmaceutical, DaShenLin Pharmaceutical, Create SD Holdings. |
| What is the current market cap of Kusuri No Aoki? | Kusuri No Aoki's current market cap is $2B. |
| What is the current revenue of Kusuri No Aoki? | Kusuri No Aoki's last 12 months revenue is $4B. |
| What is the current revenue growth of Kusuri No Aoki? | Kusuri No Aoki revenue growth (NTM/LTM) is 12%. |
| What is the current EV/Revenue multiple of Kusuri No Aoki? | Current revenue multiple of Kusuri No Aoki is 0.8x. |
| Is Kusuri No Aoki profitable? | Yes, Kusuri No Aoki is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Kusuri No Aoki? | Kusuri No Aoki's last 12 months EBITDA is $260M. |
| What is Kusuri No Aoki's EBITDA margin? | Kusuri No Aoki's last 12 months EBITDA margin is 7%. |
| What is the current EV/EBITDA multiple of Kusuri No Aoki? | Current EBITDA multiple of Kusuri No Aoki is 10.9x. |
| How many companies Kusuri No Aoki has acquired to date? | Kusuri No Aoki hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies Kusuri No Aoki has invested to date? | Kusuri No Aoki hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Kusuri No Aoki
Lists including Kusuri No Aoki
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.